$LAHO ..Global Stem..Market to Reach US$ 467 billion by 2024 ..Due to the increased funding from Government and Private sector and rising global awareness.
..Because of the economic potential of this industry (the worldwide market for regenerative medicine is conservatively estimated to be $500 billion..
An example of some conditions and diseases that could be easily cured by regenerative medicine and their current cost of treatmentt include:
250,000 patients receive heart valves, at a cost of $27 billion annually 950,000 people die of heart disease or stroke, at a cost of $351 billion annually(8) 17 million patients with diabetes, at a cost of $132 billion annually
..By doing so, we can make tissue and organ failure a relic of the past by 2020.
Interagency Federal Working Group on Regenerative Medicine
Chair Howard Zucker, MD, JD Deputy Assistant Secretary for Health U.S. Department of Health and Human Services
National Institutes of Health Donna Dean, PhD Colleen Guay-Broder, MPH Eleni Kousvelari, PhD Christine Kelley, PhD John Watson, PhD Josh Zimmerberg, PhD
Food and Drug Administration Charles Durfor, PhD Donald Fink, PhD Joyce Frey, PhD Jesse Goodman, MD Darin Weber, PhD Celia Witten, PhD
Studies a U.S. FDA-regulated Device Product: YES Estimated Study Start Date : May 13, 2019 Estimated Primary Completion Date : September 15, 2020 Estimated Study Completion Date : November 1, 2020 https://clinicaltrials.gov/ct2/show/NCT03752827